Discover the full record of transactions filed by ROBIN HOWARD W, Chairman & CEO. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 11 reports have been recorded. Total volume traded: €859k. The latest transaction was disclosed on 15 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
ROBIN HOWARD W is the President & CEO at NEKTAR THERAPEUTICS. He is responsible for the strategic direction of the company and oversees all operations. His leadership and expertise in the biopharmaceutical sector are essential for the success of the organization.